[시장보고서]병리학 전망 : 자동화 플랫폼, 디지털 이미징 및 시장 역학( 제3판)

병리학 전망 : 자동화 플랫폼, 디지털 이미징 및 시장 역학( 제3판)

The Future of Pathology: Automated Platforms, Digital Imaging, and Market Dynamics, 3rd Edition

상품코드 : 1962955

리서치사 : Kalorama Information

발행일 : 2026년 02월

페이지 정보 : 영문 120 Pages

라이선스 & 가격 (부가세 별도)

한글목차

샘플 요청 목록에 추가

병리학은 현대 임상 진단에서 여전히 기초적인 역할을 담당하고 있으며, 질병의 발견, 치료법 선택, 환자 관리를 위한 세포, 조직, 장기 수준의 지식을 제공합니다. 의료가 데이터 기반 및 개인화됨에 따라 병리학의 가치는 계속 증가하고 있습니다. 영상진단, 염색법, 분자기술의 발전으로 조직의 구조적 변화가 질병의 진행과 어떻게 연관되어 있는지에 대한 이해가 깊어지고 있습니다. 한편, 검사량 증가와 인력 부족으로 인해 검사실은 운영 방식에 대한 재검토를 요구받고 있습니다. 카라올라마 인포메이션이 발간한 '병리학의 미래 - 자동화 플랫폼, 디지털 이미징, 시장 역학(제3판)'은 2025년부터 2030년까지 추정 및 예측을 통해 이러한 시장 동향 등을 다루고 있습니다.

기술, 워크플로우, 정밀의료가 만들어가는 시장

이 분야는 진단 정확도를 높이고, 재현성을 향상시키며, 업무를 효율화하는 솔루션으로 진화하고 있습니다. 이러한 변화를 주도하는 주요 요인은 다음과 같습니다.

표준화된 대용량 병리학 워크플로우에 대한 수요 증가
종양학 및 정밀의료 용도의 중요성 증가
조직 기반 바이오마커 분석 및 다중 분석의 활용도 확대
질병에 대한 정량적이고 데이터가 풍부한 해석으로의 전환
병리 소견을 광범위한 임상 시스템에 통합하는 진전된 방법

그 결과, 디지털 병리, 자동 염색 플랫폼, 인공지능을 활용한 이미지 분석 기술이 모든 규모의 검사실에 보급되고 있습니다. 이러한 혁신 기술을 통해 복잡한 시료의 처리 속도 향상, 검사 능력 확대, 보다 일관된 해석을 가능하게 합니다. 또한 조직병리학과 체외진단의 연계를 강화하여 암 치료 과정에 병리 데이터를 심층적으로 통합할 수 있습니다.

조사 범위

이 보고서는 다음과 같은 8가지 주요 부문에 걸쳐 세계 병리학 시장을 종합적으로 분석합니다.

기존의 비PAP 염색
PAP 검사
원위 하이브리드화
면역조직화학
HPV 검사
순환 종양 세포
유세포 분석
디지털 병리

시장 추정 및 예측은 2025년과 2030년까지 제조업체 수준에서 제공되며, CAGR도 포함되어 있습니다. 2025년 경쟁 분석과 함께 북미, 유럽, 아시아태평양 및 기타 지역을 포괄하는 지역별 평가도 포함되어 있습니다. 이 추정 및 예측은 업계 전문가, 기업 관계자, 의료 서비스 제공업체, 정부 관계자와의 인터뷰를 포함한 광범위한 1차 및 2차 조사를 통해 이루어졌습니다.

큰 폭의 성장이 예상되는 시장

오랜 역사를 가진 병리학 시장은 여전히 큰 잠재력을 가진 역동적인 시장입니다. 다중화 기술, 자동화 및 디지털 분석의 혁신은 진단 능력을 확장하고 워크플로우 효율성을 향상시키며 임상과 더 깊이 통합할 수 있는 기회를 열어주고 있습니다. 기술의 발전과 세계 시장 확대에 따라 병리학 시장은 2030년 이후에도 지속적인 진화를 이룰 것으로 예측됩니다.

부문별 IVD 병리학 시장 전체
지역별 IVD 병리학 시장
(아시아태평양, 유럽, 북미, 기타 지역)
- 북미
- 유럽
- 아시아태평양
- 기타 지역
국가별 분포
IVD 병리학에 대한 COVID-19의 영향(2018년-2030년)
경쟁 분석
- IVD 병리학 분야 주요 4대 경쟁사
- Roche
- Beckton Dickinson(BD)
- Agilent
- Danaher
IVD 병리학 분야의 상업적 전망

LSH

영문 목차

영문목차

Pathology remains fundamental to modern clinical diagnostics, supplying the cellular, tissue, and organ level insights that guide disease detection, treatment selection, and patient management. As healthcare becomes more data driven and personalized, the value of pathology continues to increase. Advances in imaging, staining, and molecular techniques have improved understanding of how structural changes in tissues relate to disease progression, while rising testing volumes and workforce shortages are prompting laboratories to reassess how they operate. The Future of Pathology: Automated Platforms, Digital Imaging, and Market Dynamics, 3rd Edition by Kalorama Information covers these market trends and more with estimates and forecasts spanning 2025-2030.

A Market Shaped by Technology, Workflows, and Precision Medicine

The field is evolving toward solutions that strengthen diagnostic accuracy, improve reproducibility, and streamline operations. Several forces are driving this shift:

Growing need for standardized, high volume pathology workflows
Rising importance of oncology and precision medicine applications
Expanding use of tissue based biomarker analysis and multiplex assays
Movement toward quantitative and data rich interpretation of disease
Increasing integration of pathology findings into broader clinical systems

As a result, digital pathology, automated staining platforms, and artificial intelligence enabled image analytics are gaining traction across laboratories of all sizes. These innovations allow faster turnaround, expanded testing capacity, and more consistent interpretation of complex specimens. They also strengthen the link between anatomic pathology and in vitro diagnostics, enabling deeper incorporation of pathology data into cancer care pathways.

Scope of the Report

This Kalorama Information report provides a comprehensive analysis of the global pathology market across eight major segments:

Traditional non PAP stains
PAP tests
In situ hybridization
Immunohistochemistry
HPV testing
Circulating tumor cells
Flow cytometry
Digital pathology

Market estimates are provided at the manufacturer level for 2025 and 2030, including compound annual growth rates. Competitive analysis is included for 2025, along with regional assessments covering North America, Europe, Asia Pacific, and the Rest of the World. Estimates and forecasts were developed through extensive primary and secondary research including interviews with industry experts, company personnel, healthcare providers, and government officials.

A Market Positioned for Significant Growth

Despite its long history, pathology remains a dynamic market with substantial potential. Innovations in multiplexing, automation, and digital analysis are expanding diagnostic capability, improving workflow efficiency, and opening opportunities for deeper clinical integration. With continued technological progress and global expansion, the pathology market is poised for ongoing evolution through 2030 and beyond.

CHAPTER 1: EXECUTIVE SUMMARY

ABOUT KALORAMA INFORMATION
INDUSTRY AT A GLANCE
SCOPE AND METHODOLOGY
SIZE AND GROWTH OF THE MARKET
- Figure 1-1: Global Pathology IVD Market, 2025-2030 ($ million)
COMPETITIVE OUTLOOK

CHAPTER 2: MARKET OVERVIEW

OVERVIEW OF IVD PATHOLOGY
- Histology
- Cytology
- Digital Pathology
PATHOLOGY AND CANCER
ADVANCED ANALYSIS SOLUTIONS
- Table 2-1: Selected Advanced Pathology Techniques
LABORATORY DEVELOPED TESTS
- Laboratory Developed Tests in Pathology
AI AND PATHOLOGY

CHAPTER 3: PAP TESTS: MARKET SIZE AND GROWTH

OVERVIEW
- Table 3-1: Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2022
MARKET SUMMARY
- Table 3-2: Global PAP Test Market Trend, 2020, 2025, 2030 ($ million)
- Figure 3-1: Global PAP Test Market Trend, 2020, 2025, 2030 ($ million)
- Regional Market Overview
  - Table 3-3: Global PAP Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, ROW]
  - Figure 3-2: Global PAP Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 4: IN SITU HYBRIDIZATION: MARKET SIZE AND GROWTH

OVERVIEW
- Figure 4-1: In Situ Hybridization Indication Distribution, 2025 (%) [Oncology, Other]
- Table 4-1: Selected in Situ Hybridization-based Tests
MARKET SUMMARY
- Table 4-2: Global In Situ Hybridization Test Market Trend, 2020, 2025, 2030 ($ million)
- Figure 4-2: Global In Situ Hybridization Test Market Trend, 2020, 2025, 2030 ($ million)
- Regional Market Overview
  - Table 4-3: Global In Situ Hybridization IVD Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
  - Figure 4-3: Global In Situ Hybridization IVD Test Market, by Region, 2025-2030 [Asia Pacific, Europe, North America, RoW]

CHAPTER 5: IMMUNOHISTOCHEMISTRY: MARKET SIZE AND GROWTH

OVERVIEW
- Figure 5-1: Immunohistochemistry Distribution, by Product Type, 2025 (%) [Equipment & Instruments, Reagents]
- Table 5-1: Selected IHC Test Innovations
MARKET SUMMARY
- Table 5-2: Global Immunohistochemistry Test Market Trend, 2020, 2025, 2030 ($ million)
- Figure 5-2: Global Immunohistochemistry Test Market Trend, 2020, 2025, 2030 ($ million)
- Regional Market Overview
  - Table 5-3: Global Immunohistochemistry Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
  - Figure 5-3: Global Immunohistochemistry Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 6: HUMAN PAPILLOMAVIRUS (HPV): MARKET SIZE AND GROWTH

OVERVIEW
- Figure 6-1: HPV Screening Market: HPV DNA/RNA and Pap Test Distribution of Sales, 2025 (%)
- Table 6-1: Selected HPV Test Innovations
MARKET SUMMARY
- Table 6-2: Global HPV (DNA/RNA) Test Market Trend, 2020, 2025, 2030 ($ million)
- Figure 6-2: Global HPV (DNA/RNA) Test Market Trend, 2020, 2025, 2030 ($ million)
- Regional Market Overview
  - Table 6-3: Global HPV (DNA/RNA) Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
  - Figure 6-3: Global HPV (DNA/RNA) Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 7: CIRCULATING TUMOR CELLS (CTCS): MARKET SIZE AND GROWTH

OVERVIEW
- Table 7-1: Selected CTC Test Innovations
MARKET SUMMARY
- Figure 7-1: Circulating Tumor Cells (CTCs) Distribution, by Product Type, 2025 (%) [Consumables/Reagents, Equipment and Instruments]
- Table 7-2: Global Circulating Tumor Cells (CTCs) Test Market Trend, 2020, 2025, 2030 ($ million)
- Figure 7-2: Global Circulating Tumor Cells (CTCs) Test Market Trend, 2020, 2025, 2030 ($ million)
- Regional Market Overview
  - Table 7-3: Global Circulating Tumor Cells (CTCs) IVD Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
  - Figure 7-3: Global Circulating Tumor Cells (CTCs) Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 8: FLOW CYTOMETRY: MARKET SIZE AND GROWTH

OVERVIEW
- Table 8-1: Selected Flow Cytometry Innovations
MARKET OVERVIEW
- Table 8-2: Global Flow Cytometry Test Market Trend, 2020, 2025, 2030 ($ million)
- Figure 8-1: Global Flow Cytometry Test Market Trend, 2020, 2025, 2030 ($ million)
- Regional Market Overview
  - Table 8-3: Global Flow Cytometry Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
  - Figure 8-2: Global Flow Cytometry Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 9: TRADITIONAL NON-PAP TISSUE STAINS: MARKET SIZE AND GROWTH

OVERVIEW
- Table 9-1: Selected Traditional Tissue Stain Test Innovations
- Table 9-2: Selected Vendors of Traditional Pathology Stains
MARKET SUMMARY
- Table 9-3: Global Traditional non-Pap Tissue Stains Test Market Trend, 2020, 2025, 2030 ($ million)
- Figure 9-1: Global Traditional non-Pap Tissue Stains Test Market Trend, 2020, 2025, 2030 ($ million)
- Regional Market Overview
  - Table 9-4: Global Traditional non-Pap Tissue Stains Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
  - Figure 9-2: Global Traditional non-Pap Tissue Stains Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 10: DIGITAL PATHOLOGY: MARKET SIZE AND GROWTH

OVERVIEW
- Component Overview
- Digital Pathology Software
- Digital Pathology Scanners
- Brightfield
- Fluorescence
- Whole Slide Imaging
- A. Menarini Diagnostics
- Huron Digital Pathology
- PerkinElmer
- Digital Pathology Communication and Storage
- Table 10-1: Selected Digital Pathology Innovations
APPLICATIONS
- Digital Pathology for Precision Medicine
- Digital Pathology for Research and Education
- Digital Pathology for Disease Diagnostics
- Hospitals
- Diagnostic Laboratories
- Post-Pandemic Normalization
- Outpatient Clinics
- Other Areas of Digital Pathology (Research Applications)
- Biotech and Pharmaceutical Applications
- Education and Research Applications
MARKET SUMMARY
- Table 10-2: Digital Pathology Markets, by Component, 2025 ($ million) [Clinical Support Services, Hardware, Software]
- Figure 10-1: Digital Pathology Markets, by Component, 2025 (%) [Clinical Support Services, Hardware, Software]
- Table 10-3: Global Digital Pathology Test Market Trend, 2020, 2025, 2030 ($ million)
- Figure 10-2: Global Digital Pathology Test Market Trend, 2020, 2025, 2030 ($ million)
- Regional Market Overview
  - Table 10-4: Global Digital Pathology Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
  - Figure 10-3: Global Digital Pathology Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 11: TOTAL IVD PATHOLOGY MARKET

Table 11-1: Total IVD Pathology Market, Sales and Market Share by Segment, ($ million) (%) 2025-20230 [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
Figure 11-1: Total Global IVD Pathology Market, 2020-2030 ($ million)
TOTAL IVD PATHOLOGY MARKET BY SEGMENT
- Figure 11-2: Global IVD Pathology Market, by Segment Distribution, 2025 (%) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
- Figure 11-3: Total IVD Pathology Annual Growth, by Segment, 2020-2030 (%) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
IVD PATHOLOGY MARKET BY REGION
- Table 11-2: Global Pathology Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
- Figure 11-4: Global Pathology Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
- Table 11-3: Global Pathology Sales Distribution, by Region, 2025-2030 (%)
[Asia Pacific, Europe, North America, RoW]
- North America
  - Table 11-4: North America Pathology Market, by Segment, 2025-2030 ($ million) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
- Europe
  - Table 11-5: Europe Pathology Market, by Segment, 2025-2030 ($ million) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
- Asia Pacific
  - Table 11-6: Asia Pacific Pathology Market, by Segment, 2025-2030 ($ million) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
- Rest of World
  - Table 11-7: Rest of World Pathology Market, by Segment, 2025-2030 ($ million) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
COUNTRY DISTRIBUTION
- Figure 11-5: Total Global IVD Pathology Market Share, by Country, 2025 (%) [Australia, Canada, China, France, Germany, Italy, Japan, Spain, United Kingdom, United States, RoW]
IVD PATHOLOGY COVID-19 IMPACT 2018-2030
- Historical
- The COVID-19 Era
- Post-COVID-19 IVD Pathology
- Future IVD Pathology
  - Figure 11-6: COVID-19 Pandemic Impact on the IVD Pathology Market, 2018-2030 (%)
COMPETITIVE ANALYSIS
- Table 11-8: Revenues of the Major Pathology Companies, 2020-2025 ($ million)
- Figure 11-7: Global IVD Pathology Competitive Summary, 2025 (%)
- Top Four IVD Pathology Competitors
- Roche
  - Table 11-9: Pathology Launches by Roche
- Beckton Dickinson (BD)
- Agilent
- Danaher
THE COMMERCIAL OUTLOOK FOR IVD PATHOLOGY

한글목차

기술, 워크플로우, 정밀의료가 만들어가는 시장

조사 범위

큰 폭의 성장이 예상되는 시장

목차

제1장 주요 요약

제2장 시장 개요

제3장 팹 테스트 : 시장 규모와 성장

제4장 IN SITU HYBRIDIZATION : 시장 규모와 성장

제5장 면역조직화학 : 시장 규모와 성장

제6장 인유두종바이러스(HPV) : 시장 규모와 성장

제7장 순환종양세포(CTCS) : 시장 규모와 성장

제8장 유세포분석기 : 시장 규모와 성장

제9장 기존 비PAP 조직 염색 : 시장 규모와 성장

제10장 디지털 병리학 : 시장 규모와 성장

제11장 IVD 병리학 시장 전체